Dapagliflozin improves outcomes for elderly TAVR patients with heart failure

Sergio Raposeiras-Roubin, MD, presenting new data on TAVR and dapagliflozin at ACC.25 in Chicago

Sergio Raposeiras-Roubin, MD, a clinical cardiologist at Álvaro Cunqueiro Hospital in Vigo, Spain, presents late-breaking data at ACC.25 in Chicago.

The positive data were presented as part of a late-breaking clinical trial at ACC.25 in Chicago. One cardiologist on stage for the presentation said these findings will impact the way he manages certain TAVR patients.